Drug Type Monoclonal antibody |
Synonyms 23C6-antibody(TellBio) |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Tellbio, Inc.Startup |
Active Organization Tellbio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | Tellbio, Inc.Startup | 28 Oct 2022 |
Pancreatic Cancer | Preclinical | US | Tellbio, Inc.Startup | 28 Oct 2022 |